LED vs Laser Hair Growth Devices in Canada vs the US: Which Type Works and Which Rules Apply?
LED and laser hair growth devices are usually sold in the same aisle and described with the same words: red light, 650 nanometres, low-level light therapy. They are not the same device, and the difference is not the colour of the light. What separates them is how the light is generated, how it is delivered across the scalp, and how the energy is measured. That last point is the one that decides whether two specification sheets can be compared at all.
This guide sets out the physical difference between the two device types, the measurement that actually lets them be compared, the published evidence base, and the regulatory difference between Canada and the United States. It does not cover treatment technique, dosing or patient selection, because those belong to the manufacturer's instructions for use and the clinic's own written protocol.
Are LED and laser hair growth devices the same thing?
They are two different light sources that share a therapeutic wavelength band. A laser generates light by stimulated emission, which produces coherent, monochromatic and highly directional light — the waves stay in phase with one another and can be focused into a narrow beam. An LED generates light by spontaneous emission, which produces narrowband but non-coherent light that spreads across a wider area with no beam to focus.
That difference is real physics, and it is why laser devices historically used combs or spot arrays, while LED devices are built as panels, caps and hoods that cover a larger area of scalp. It is also why the evidence base is harder to split than the marketing suggests. The 2025 systematic review and meta-analysis of light-based treatment in alopecia is titled Low-Level Laser and LED Therapy in Alopecia and pools the two device types into a single analysis, because the studies largely report their outputs in the same units regardless of source.
For a buyer, the useful conclusion is that "laser versus LED" is not the axis that determines whether a device will be effective. The axis that matters is whether the device delivers the required energy density evenly across the target area, over a session duration that a patient will actually complete.
Which physical differences between LED and laser devices matter to a buyer?
Five parameters separate one device from another, and only two of them are usually printed on the box.
| Parameter | What it describes | Unit | Published example |
|---|---|---|---|
| Wavelength | The colour of the light and how deeply it penetrates tissue | nm | 650 nm red; near-infrared around 830 nm |
| Irradiance, or power density | Optical power delivered per unit area | mW/cm² | Device-specific, and often not published |
| Energy density, or fluence | Total energy delivered per unit area, equal to irradiance multiplied by exposure time | J/cm² | 40 J/cm² delivered over 20 minutes in a red and green LED trial |
| Coherence | Whether the light waves stay in phase; a laser is coherent, an LED is not | not applicable | Laser coherent; LED non-coherent |
| Session duration | How long the light is applied per session | minutes | 20 minutes in the same trial |

The arithmetic behind the energy density line is worth doing once, because it is the calculation that makes two devices comparable. Forty joules per square centimetre delivered over twenty minutes is forty joules divided by 1,200 seconds, which is about 0.033 watts per square centimetre, or roughly 33 milliwatts per square centimetre of average irradiance over the session.
Two further practical differences follow from the physics. The first is coverage: a small laser comb treats a moving strip of scalp and depends on the operator moving it systematically, while a cap or panel with many emitters treats the whole area at once with an energy distribution that varies by position. Coverage matters because the published trials report outcomes for the treated scalp area, not for the device. The second is the effective emitting area: a device that reports a single figure for total optical power tells the buyer nothing about irradiance unless the emitting area is also given, since the same wattage spread over twice the area halves the energy density.
A device described only by diode count and wavelength cannot be compared against one described by energy density and session time, because the two descriptions do not measure the same quantity.
What does the clinical evidence show for light-based hair growth devices?
The strongest single source is the 2025 meta-analysis, which pooled 38 studies covering 3,098 patients, of whom 2,930 had androgenetic alopecia. The mean change in hair density increased significantly compared with placebo, with a standardised mean difference of 1.14 (95 per cent confidence interval 0.51 to 1.78) for treatment shorter than 20 weeks and 1.44 (95 per cent confidence interval 0.97 to 1.91) for treatment longer than 20 weeks. The review's own conclusion is measured: promising for androgenetic alopecia, with insufficient statistical information to pool the other alopecia types. The same review notes that the pooled evidence base is laser and LED combined.
A 2024 randomised comparative trial used an LED helmet that delivered 40 joules per square centimetre over 20 minutes to each half of the frontal scalp, with red light on one side and green on the other. Seventeen participants were treated for six months. Both red and green LED light significantly increased hair diameter, non-vellus hair density and satisfaction scores, and the red arm produced a greater increase in hair diameter than the green arm. Reported adverse effects were mild and limited to scalp heat and transient redness.
The most instructive study for a buyer is the smallest one. A 2023 randomised controlled trial assigned 54 patients with androgenetic alopecia to either low-level laser therapy twice weekly plus 5% minoxidil solution, or 5% minoxidil solution alone, and followed both groups for 16 weeks. Hair density improved by 14.78 per cent in the combined group and 11.43 per cent in the minoxidil-only group, and the difference did not reach significance, with a p value of 0.45. Physician global assessment and patient satisfaction scores also showed no significant difference between the groups. In other words, adding a light device to an established treatment did not demonstrate an additional benefit in that trial, even though light therapy on its own performs better than placebo in pooled analysis.
That is the honest position to give a procurement committee: light-based devices have reasonable evidence as a treatment for androgenetic alopecia against placebo, the evidence does not establish an advantage over established medical therapy in the one randomised head-to-head trial that added light to a drug, and the evidence for other forms of hair loss is thin. A 2016 Cochrane review of interventions for female pattern hair loss and a 2025 umbrella review of photobiomodulation trials point in the same direction — several modalities with modest, imperfectly measured effects.

Do Canada and the United States regulate hair growth devices the same way?
No, and the vocabulary that each market uses is the clearest signal of which regime is being described.
| Item | Canada | United States |
|---|---|---|
| Instrument that authorises the device | Medical Devices Regulations; Class II, III and IV devices each require a Medical Device Licence before they can be sold | 21 CFR Part 807, Subpart E, premarket notification — the submission usually called a 510(k) |
| Classification entry covering the product family | A Class II device family, with the licence number checkable in the Medical Devices Active Licence Listing | 21 CFR 890.5500, product code OAP, titled Laser, Comb, Hair, Class II, described as a device to promote hair growth in males with androgenetic alopecia |
| Wording a buyer will see on the listing | Licensed for sale in Canada, with a licence number | Cleared, with a 510(k) number |
| Neighbouring category that is easy to confuse | Not applicable | Light-based over-the-counter hair removal, 21 CFR 878.4810, product code OHT, Class II |
| What an authorisation in one country does not do | A United States clearance does not permit sale in Canada | A Canadian licence does not permit marketing in the United States |
The trap here is a single regulatory fact used in the wrong market. Searching a device database for the word "hair" returns both a hair growth entry and a hair removal entry, and the two have different regulation numbers and different product codes. A procurement document that copies a clearance number from a hair removal device into a specification for a hair growth device is describing a different product with an opposite function. The other trap is assuming that a clearance transfers, which it does not: the Canadian requirement is a licence issued under the Canadian regulations, and the licence number is the thing to verify.
There is also a product safety layer that applies to both countries regardless of the licensing route. The international laser product safety standard is IEC 60825-1, which classifies laser products by accessible emission limits and sets the control measures that follow from the class. A device that emits laser light should be able to state its class under that standard; an LED-based device with no laser source is not classified under it at all, which is another practical difference between the two types that shows up in the documentation rather than in the marketing.
How should you read a device specification sheet?
Ask for the same six items from every vendor, in writing, and the comparison becomes mechanical.
- Wavelength in nanometres, including whether more than one wavelength is emitted.
- Energy density in joules per square centimetre for a single session.
- Session duration in minutes, so that average irradiance can be calculated.
- Number of emitters and the emitting area, so that irradiance can be checked against energy density.
- Authorisation, stated as either a Canadian Medical Device Licence number or a United States 510(k) number, with the market it applies to.
- The treated area and the population in the study the vendor relies on, because an outcome reported for a treated scalp area is not the same as an outcome for a whole head.
A specification sheet that answers all six is comparable with any other sheet that answers all six. A sheet that answers only wavelength and diode count is a marketing document, and two marketing documents cannot be compared with each other.
Ordering for a clinic, lab or care home? Wholesale and multi-site ordering covers case pricing and account setup, and the B2B wholesale collection lists the lines stocked for institutional buyers. Devices and accessories for treatment rooms are grouped in the medical aesthetics collection and the therapy devices collection, alongside routine consumables such as blue nitrile examination gloves, disposable non-woven bed sheets and dry disposable washcloths by the case.
References and standards cited
- Perez SM, Vattigunta M, Kelly C, Eber A. Low-level laser and LED therapy in alopecia: a systematic review and meta-analysis. Dermatol Surg. 2025;51(2):179-183 (link checked 27 September 2026)
- Tantiyavarong J, Charoensuksira S, Meephansan J, et al. Red and green LED light therapy: a comparative study in androgenetic alopecia. Photodermatol Photoimmunol Photomed. 2024;40(6):e13004 (link checked 27 September 2026)
- Sondagar DM, Mehta HH, Agharia RS, Jhavar MK. Efficacy of low-level laser therapy in androgenetic alopecia — a randomized controlled trial. Int J Trichology. 2023;15(1):25-32 (link checked 27 September 2026)
- Cochrane Database of Systematic Reviews, interventions for female pattern hair loss (link checked 27 September 2026)
- Lasers in Medical Science, low-level laser therapy for the treatment of androgenic alopecia: a review (link checked 27 September 2026)
- Journal of Cosmetic Dermatology, the use of light-based therapies in the treatment of alopecia (link checked 27 September 2026)
- Systematic Reviews, effects of photobiomodulation on multiple health outcomes: an umbrella review of randomized clinical trials (link checked 27 September 2026)
- Cornell Legal Information Institute, 21 CFR 890.5500 — laser, comb, hair (link checked 27 September 2026)
- Electronic Code of Federal Regulations, 21 CFR 890.5500 — laser, comb, hair (link checked 27 September 2026)
- United States Food and Drug Administration, CFR search result for 21 CFR 890.5500 (link checked 27 September 2026)
- United States Food and Drug Administration, product classification for code OAP (laser, comb, hair) (link checked 27 September 2026)
- United States Food and Drug Administration, product classification for code OHT (light based over-the-counter hair removal) (link checked 27 September 2026)
- Cornell Legal Information Institute, 21 CFR 878.4810 — powered light based instruments and laser surgical instruments (link checked 27 September 2026)
- Electronic Code of Federal Regulations, 21 CFR Part 807 Subpart E — premarket notification procedures (link checked 27 September 2026)
- openFDA device classification API, the public interface used to retrieve the product-code records cited above (link checked 27 September 2026)
- Canadian Centre for Occupational Health and Safety, OSH Answers fact sheet on lasers (link checked 27 September 2026)
- International Electrotechnical Commission, IEC 60825-1 safety of laser products — Part 1: equipment classification and requirements (link checked 27 September 2026)
- Public Health Ontario, infection prevention and control in personal service settings (link checked 27 September 2026)
Related Reading
- Laser Cap Therapy for Hair Loss: What Clinicians Tell Patients
- LED Light Therapy Face Masks: Do They Actually Work? A Practical Guide
- Handheld LED Red Light Therapy Devices: Clinical Evidence for Canadian Clinics and Home Use
- Medical aesthetics collection — light and energy devices
- Learning hub — procurement and compliance guides
Frequently Asked Questions
Are LED helmets and laser caps the same thing?
No. Both deliver red or near-infrared light to the scalp, and both are sold as low-level light therapy, but a laser produces coherent, monochromatic light through stimulated emission, while an LED produces non-coherent narrowband light through spontaneous emission. The clinical literature frequently pools the two: the 2025 systematic review and meta-analysis of light-based treatment in alopecia is titled Low-Level Laser and LED Therapy in Alopecia and analyses them as one evidence base. The practical difference for a buyer is coverage and delivery of energy density across the scalp, not the label on the box.
What should a buyer check before comparing two light-based hair growth devices?
Four numbers, in this order: wavelength in nanometres, energy density in joules per square centimetre, session duration in minutes, and the number and layout of the light emitters. Energy density divided by session time gives the average irradiance, which is the figure that lets two differently-described devices be compared on the same basis. A device described only by wavelength and diode count cannot be compared with one described by energy density, because the two descriptions do not measure the same thing.
Does a United States 510(k) clearance mean a hair growth device can be sold in Canada?
No. A premarket notification clearance issued by the United States Food and Drug Administration applies to the United States market. Selling a Class II device in Canada requires a Medical Device Licence issued under the Medical Devices Regulations, and the licence number can be checked in the Medical Devices Active Licence Listing. A device can hold one authorisation and not the other, so a buyer should always ask which authorisation is being described and where it applies.
What is the difference between a hair growth device and a hair removal device?
They are different regulated categories with opposite purposes. In the United States, a light-based over-the-counter hair removal device sits at 21 CFR 878.4810 under product code OHT, described as a device that uses thermal energy to kill hair follicles. A light-based hair growth device sits at 21 CFR 890.5500 under product code OAP, described as a device to promote hair growth in males with androgenetic alopecia. Confusing the two is a common procurement error, because both categories contain laser and LED products and both are Class II.
What wavelength do light-based hair growth devices use?
Most devices in the published trials and in the commercial market use red light in the 630 to 670 nanometre range, with some devices adding near-infrared emitters around 830 nanometres. A red and green LED trial in androgenetic alopecia delivered 40 joules per square centimetre over 20 minutes and found that both red and green light increased hair diameter and non-vellus hair density, while the red arm produced the greater gain in hair diameter. Wavelength alone does not predict performance, because the same wavelength can be delivered at very different energy densities.
What does energy density mean on a hair growth device specification sheet?
Energy density, also called fluence, is the total optical energy delivered per unit area, expressed in joules per square centimetre. It equals irradiance multiplied by exposure time, so 40 joules per square centimetre delivered over 20 minutes corresponds to an average irradiance of about 33 milliwatts per square centimetre. A specification that quotes only diode count or wattage does not let a buyer calculate this, which is why energy density and session time should be requested together.
Is photobiomodulation the same as low-level laser therapy?
The two terms overlap heavily in current use. Photobiomodulation is the broader term for using non-ionising light to influence cell behaviour, and it covers laser and LED sources. Low-level laser therapy is the older term and names the laser source specifically. A 2025 umbrella review of randomised trials on photobiomodulation treats the field as one body of evidence, and the alopecia review cited above pools laser and LED together, so a specification sheet using either term is describing the same broad mechanism.
Where can a clinic or care home order supplies in case quantities?
Institutional buyers normally order by case rather than by the single pack, and account set-up sits on the wholesale side rather than the consumer checkout. Case configurations and the institutional catalogue cover the lines stocked for clinics, care homes and multi-site operators, which is the practical route for a facility that is equipping treatment rooms or restocking consumables alongside a device purchase.
Last updated: September 2026. CliniEco Medical is a licensed medical device establishment (MDEL #35334).
0 commentaire